Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 is trading up, hitting a new high of 7901 point and, eclipsing the last record set on the 8th of March at 7847 points.
Materials led intraday gains, up 2.2 per cent, after real estate had initially set the pace at1.8 per cent.
The IT sector was the only sector falling mid-morning by three of a per cent.
The ABS released Retail and sales data this morning, reporting retail sales climbed 0.3 per cent in February, falling just short of expectations.
Oxford economics attributed the boost to the recent Taylor swift eras tour.
Today WA1 Resources, AIC Mines, and Argenica Therapeutics came into view.
WA1 Resources (ASX:WA1) has announced results from drilling at the 100% owned West Arunta Project in Western Australia.
43 reverse circulation (RC) drillholes and three diamond drillholes were completed, hitting high grad intercepts of niobium among the latest assay results.
Over the last year, WA1 Resources shares have posted 1Y returns of 840.94%.
The company is outperforming the ASX200 by 771% and has a market cap of $732.9M.
WA1 has been trading at $11.95.
AIC Mines (ASX: A1M) has raised expectations for its Jericho copper deposit in north Queensland.
The company posted an update to its ore reserve estimate, showing an 86 percent increase in contained copper and a further 86 percent in contained gold.
The new ore reserve now sits at 3.2 million tonnes at grades of 1.9 percent copper and 0.4 grams per tonne of gold.
Argenica Therapeutics (ASX:AGN) shares are up nearly 19 per cent, as the company initiated dosing for the first acute ischemic stroke (AIS) patient in its Phase 2 clinical trial of ARG007.
The Phase 2 trial, named SEANCON, aims to assess ARG007’s safety in AIS patients, a crucial step leading up to potential Phase 3 trials and fostering collaborations with global pharmaceutical firms.
AGN has been trading at 70 cents.
That’s market update, we’ll see you later for market
